Abstract
Sirtuins are type III histone deacetylases (HDAC) that uses nicotinamide adenine dinucleotide as cosubstrate. Dysfunction of sirtuins is implicated in wide varieties of human diseases. As such, there has been increased interest in the development of small molecule to modulate sirtuin activities. Besides deacetylase activity, recent studies suggest SIRT1, 2, 3, and 6 efficiently remove fatty acyl groups on lysine. In vitro sirtuin enzymatic activity assays established so far are mainly based on the deacetylation activity. Here, we describe a fluorogenic assay for monitoring defatty-acylase activity of SIRT1, 2, 3 and 6 using peptide substrates. This assay can be utilized to evaluate sirtuin modulators in high-throughput manners.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Imai S, Guarente L (2014) NAD+ and sirtuins in aging and disease. Trends Cell Biol 24(8):464–471. https://doi.org/10.1016/j.tcb.2014.04.002
Hu J, Jing H, Lin H (2014) Sirtuin inhibitors as anticancer agents. Future Med Chem 6(8):945–966. https://doi.org/10.4155/fmc.14.44
Guarente L (2011) Sirtuins, aging, and medicine. N Engl J Med 364(23):2235–2244. https://doi.org/10.1056/NEJMra1100831
Feldman JL, Baeza J, Denu JM (2013) Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J Biol Chem 288(43):31350–31356. https://doi.org/10.1074/jbc.C113.511261
He B, Hu J, Zhang X, Lin H (2014) Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors. Org Biomol Chem 12(38):7498–7502. https://doi.org/10.1039/c4ob00860j
Teng Y-B, Jing H, Aramsangtienchai P, He B, Khan S, Hu J, Lin H, Hao Q (2015) Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies. Sci Rep 5:8529. https://doi.org/10.1038/srep08529
Zhang X, Khan S, Jiang H, Antonyak MA, Chen X, Spiegelman NA, Shrimp JH, Cerione RA, Lin H (2016) Identifying the functional contribution of the defatty-acylase activity of SIRT6. Nat Chem Biol 12(8):614–620. https://doi.org/10.1038/nchembio.2106
Jing H, Zhang X, Wisner SA, Chen X, Spiegelman NA, Linder ME, Lin H (2017) SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a. eLife 6. https://doi.org/10.7554/eLife.32436
Zhang X, Spiegelman NA, Nelson OD, Jing H, Lin H (2017) SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation. eLife 6:e25158. https://doi.org/10.7554/eLife.25158
Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet J-C, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science 317(5837):516–519. https://doi.org/10.1126/science.1143780
Jing H, Hu J, He B, Negrón Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang Y-L, Southard T, Giannakakou P, Weiss RS, Lin H (2016) A SIRT2-selective inhibitor promotes c-Myc oncoprotein degradation and exhibits broad anticancer activity. Cancer Cell 29(3):297–310. https://doi.org/10.1016/j.ccell.2016.02.007
Chiang YL, Lin H (2016) An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3. Org Biomol Chem 14(7):2186–2190. https://doi.org/10.1039/c5ob02609a
Hu J, He B, Bhargava S, Lin H (2013) A fluorogenic assay for screening Sirt6 modulators. Org Biomol Chem 11(32):5213–5216. https://doi.org/10.1039/c3ob41138a
Avalos JL, Bever KM, Wolberger C (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17(6):855–868. https://doi.org/10.1016/j.molcel.2005.02.022
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Young Hong, J., Cao, J., Lin, H. (2019). Fluorogenic Assays for the Defatty-Acylase Activity of Sirtuins. In: Linder, M. (eds) Protein Lipidation. Methods in Molecular Biology, vol 2009. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9532-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9532-5_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9531-8
Online ISBN: 978-1-4939-9532-5
eBook Packages: Springer Protocols